metformin has been researched along with ursolic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JS; Jung, HA; Min, BS; Paudel, P; Seong, SH | 1 |
| Deng, S; Hann, SS; Tang, Q; Wu, J; Yang, L; Yie, Y; Zhao, S; Zheng, F | 1 |
| Chen, X; Jiang, K; Shao, J; Shen, Z; Wu, P; Xu, A; Yang, X; Zheng, G | 1 |
| Ahuja, S; Akhtar, A; Kumar, A; Mourya, A; Sah, SP | 1 |
4 other study(ies) available for metformin and ursolic acid
| Article | Year |
|---|---|
Structure-related protein tyrosine phosphatase 1B inhibition by naringenin derivatives.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Hep G2 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2017 |
Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPKα-mediated reduction of DNA methyltransferase 1.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Inhibitory Concentration 50; Metformin; Phosphorylation; Protein Processing, Post-Translational; Sp1 Transcription Factor; Triterpenes; Ursolic Acid | 2015 |
Synergistic Chemopreventive and Therapeutic Effects of Co-drug UA-Met: Implication in Tumor Metastasis.
Topics: Animals; Cadherins; Cell Line, Tumor; Drug Synergism; Female; Humans; Metformin; Mice; Neoplasm Metastasis; Neoplasms; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Triterpenes; Ursolic Acid; Vimentin; Xenograft Model Antitumor Assays | 2017 |
Synergistic action of ursolic acid and metformin in experimental model of insulin resistance and related behavioral alterations.
Topics: Acetylcholinesterase; Adiponectin; Animals; Behavior, Animal; Blood Pressure; Body Weight; Brain; Cognition; Corticosterone; Disease Models, Animal; Drug Synergism; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Mice; Organ Size; Oxidative Stress; Spleen; Triterpenes; Tumor Necrosis Factor-alpha; Ursolic Acid | 2018 |